As leaders in Real World Evidence Generation and experts in understanding patients and HCPs, we are here to partner with you and support with
- Broad and deep disease area understanding
- Evidence needs and gaps, incl. publications development
- Insights feeding into your strategy
The Gastroenterology DSPs portfolio covers well established therapy areas alongside areas with limited treatment options and consequently, limited real-world data.
We are running wave 9 of the IBD (Ulcerative colitis and Crohn’s disease) DSP in 2026, with data available from Q3. This captures evolving treatment landscape dynamics, including enriched samples of patients receiving etrasimod, guselkumab, mirikzumab, risankizumab, and upadacitinib.
There is in house data covering Celiac disease, and we are launching the first IBS programme – indications where there are no treatment options other than symptomatic management. The DSPs provide a comprehensive overview of those therapy areas, supporting market entry strategies.
With the increasing exploration and use of GLP1s, we are collecting data on patients with IBD and IBS, receiving GLP1. Whilst there are clinical trials across a range of diseases, real world data on patients with Autoimmune conditions receiving GLP1 is very limited and with that – the Adelphi dataset unique.
Gastroenterological Conditions Disease Specific Programmes (DSP) Portfolio
The DSPs answer a broad range of objectives, exploring in depth patient sub-groups:
- Understanding patient populations beyond disease presentation: clinical outcomes & PROMs defining true disease control and what matters to patients most
- Improving patient experience across their disease journey
- Real world effectiveness of newly launched products, incl. across autoimmune indications
- Treatment utilisation patterns, incl. dosing and administration, switching and reasons for switching
- Patients’ quality of life, clinical and economical disease burden
- Patient equity and treatment access disparities
Topics we have published recently on include:
- Patient journey: diagnosis, management, classification - Click here to view example
- Treatment landscape and real-world drug use and effectiveness – Click here to view example
- Alignment of patient-physician perspectives – Click here to view example
- Patient unmet needs – Click here to view example
- Economic burden of illness – Click here to view example